lenalidomide,rituximab,acalabrutinib
astrazeneca
['mantle,(-dismantle)', 'lenalidomide', 'elevate,(-elevate uc),(-elevateuc),(-elevate-uc),(-elevate rr),(-elevaterr),(-elevate-rr),(-elevate tn),(-elevatetn),(-elevate-tn)', 'ritux', 'acalabrutinib', ' lena', 'lymphoma', 'lymsm', 'imab ']
dr ruan presents acala lenalidomide and rituximab in 1l mantle cell lymphoma #ash22 #lymsm
- highly active but 43% g3+ rash 
Haematologist, Sir Charles Gairdner & Hollywood Private Hospitals
Professor, University of Western Australia
Founder/Director, Blood Cancer Research WA #lymSM